	Ebitda		日
Acadia Pharmaceuticals	USD 20.31M	15.44M	2025-12
Adma Biologics	USD 61.07M	12.52M	2026-03
ALKERMES	USD 80.26M	20.05M	2026-03
Alterity Therapeutics Limited	AUD -7.72M	2.99M	2023-06
AstraZeneca	USD 5.67B	1.29B	2026-03
BioCryst Pharmaceuticals	USD 51.7M	30.14M	2025-09
Bristol-Myers Squibb	USD 2.88B	1.36B	2025-12
Cipla	INR 9.55B	3B	2026-03
Clal Biotechnology	ILS -5.3M	2.09M	2022-12
Compugen	USD -9.02M	1.12M	2026-03
CSL	USD 3.13B	1.17B	2025-12
Eli Lilly	USD 12.14B	4.26B	2025-12
Esperion Therapeutics	USD -9.93M	24.99M	2025-09
GlaxoSmithKline	GBP 2.77B	1.65B	2026-03
Grifols	EUR 482.04M	7.04M	2025-09
Halozyme Therapeutics	USD 219.57M	197.66M	2026-03
Ionis Pharmaceuticals	USD -200.02M	42.89M	2025-12
J&J	USD 7.19B	2.32B	2025-12
Merck	USD 6.3B	2.09B	2025-12
Minerva Neurosciences	USD -4.36M	1.71M	2024-09
Neurocrine Biosciences	USD 193.3M	25.1M	2026-03
Novartis	USD 5.3B	530M	2026-03
Novavax	USD 19.36M	190.79M	2025-12
Pfizer	USD 5.99B	5.23B	2026-03
Roche Holding	CHF 12.68B	2.36B	2024-06
Sanofi	EUR 3.31B	3.65B	2026-03
Takeda	JPY 150.25B	297.88B	2026-03
Vanda Pharmaceuticals	USD -8.31M	2.37M	2024-12